Zoll
December 16, 2011
Text size
–
+
Zoll Medical Corp., a maker of resuscitation devices, rose the most in almost two decades after Medicare said it will continue to cover the company’s wearable LifeVest defibrillator. Zoll climbed 29 percent to $60.29 at the close in New York, the biggest single-day increase since the company first offered shares to the public in July 1992. Administrators with Medicare, the U.S. health-care program for the elderly and disabled, withdrew a proposed reimbursement change that would have delayed use of LifeVest, which has been covered since 2005, Chelmsford, Massachusetts-based Zoll said in a statement.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
